Published • loading... • Updated
Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
Summary by Financial Post
2 Articles
2 Articles
Financial PostReposted by 
HealthTech HotSpot
HealthTech HotSpotEurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
MISSISSAUGA, Ontario — Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga. The expanded laboratories are designed to support the growing demand for enhanced flexibility as part of process development, scale-up, and manufacturing activities for non-high potent and high potent programs. Together, the suites cover […]
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
